Amedisys, Inc.

NasdaqGS:AMED

Market Cap

USD 3.20 B

Share Price

USD 97.46

Avg Daily Volume

403,183

Change (1 day)

-0.01%

Change (1 year)

-0.28%

Change (YTD)

7.35%

Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 6.66%

Amedisys, Inc. EBIT Margin is 6.66% for the Trailing 12 Months (TTM) ending March 31, 2025, a 85.11% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 3.60%, a -54.81% change year over year.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 7.96%, a -33.50% change year over year.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 11.97%, a 16.51% change year over year.
  • Amedisys, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 10.27%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin